Simulations Plus Inc (SLP) FinancialsSLPFinancialSimulations Plus Inc

Simulations Plus, Inc. (SLP) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Software licenses, accounting for 57.6% of total sales, equivalent to $12.61M. Another important revenue stream is Consulting services. Understanding this composition is critical for investors evaluating how SLP navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Simulations Plus, Inc. maintains a gross margin of 69.12%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 20.56%, while the net margin is 16.33%. These profitability ratios, combined with a Return on Equity (ROE) of 6.17%, provide a clear picture of how effectively SLP converts its operational activities into shareholder value.

In the context of the broader market, SLP competes directly with industry leaders such as ECX and RBBN. With a market capitalization of $371.13M, it holds a significant position in the sector. When comparing efficiency, SLP's gross margin of 69.12% stands against ECX's 19.76% and RBBN's 44.11%. Such benchmarking helps identify whether Simulations Plus, Inc. is trading at a premium or discount relative to its financial performance.

Simulations Plus has shown a significant recovery in profitability with a net income of $3.58 million in Q3 2026, a turnaround from a loss of $67.32 million in the same quarter last year. The gross margin has improved to 69.12% in Q3 2026, indicating strong operational efficiency.